Flucloxacillin (floxapen) in the treatment of skin and upper respiratory tract infections.
An appraisal of flucloxacillin (floxapen) for the treatment of infection of the skin and upper respiratiory tract was carried out in general practice by 34 doctors. The success rate in the treatment of skin infections was assessed as 92 percent and in upper respiratory tract infections as 84 percent. The incidence of side effects overall was 9.5 percent and their nature and severity are described. Also the results of the present study are compared with previous appraisals of flucloxacillin in general practic and the difference in dose regimes used in these studies is discussed.
D000293:Adolescent; D000328:Adult; D000368:Aged; D002648:Child; D002675:Child, Preschool; D003023:Cloxacillin / Q000031:analogs & derivatives*; D005194:Family Practice; D005436:Floxacillin / Q000009:adverse effects / Q000627:therapeutic use*; D006801:Humans; D008875:Middle Aged; D010349:Patient Compliance; D012141:Respiratory Tract Infections / Q000188:drug therapy*; D012874:Skin Diseases, Infectious / Q000188:drug therapy*
D005436:Floxacillin; D003023:Cloxacillin